• Award-winning pharma packaging

    Pharmapack Europe has revealed the winners of the 2018 Pharmapack Awards. Elliot Gardner profiles the six winning packaging systems, from a motor-driven disposable auto-injector to an all-in-one contactless multidose delivery...

  • Block and lock: a functional cure for HIV?

    New research has opened the door to a completely different approach to tackling HIV infections. Elly Earls meets lead author of the study, Susana Valente, to find out more.

  • Is a universal flu vaccine on the horizon?

    Oxford University spin-out company Vaccitech is trialling what it hopes will be a more effective, universal flu vaccine. The company recently raised £20m from investors including Google parent firm Alphabet,...

  • Pharma Technology Focus – Issue 68

    In this issue: The benefits of seamless clinical trials, a new functional cure for HIV, using mRNA to target cancer tumours, the potential of magnetic hyperthermia in killing cancerous cells,...

  • Breaking cancer’s drug addiction

    Cancer cells can become addicted to the drugs designed to kill them, and now a group of scientists from the Netherlands Cancer Institute has discovered the underlying mechanism. Abi Millar...

  • Pharma Technology Focus – Issue 66

    In this issue: Breaking cancer’s drug addiction, the NHS’ decision to switch from biologics to biosimilars, Elsevier’s common model for data sharing, a generic antiretroviral for HIV/AIDS, the opioid addiction...

  • Bringing the NHS and pharma closer together

    One big theme in the UK’s recently published Life Science Industrial Strategy report is developing more collaboration between the NHS and the pharma industry. Abi Millar looks into how this...

  • A new approach to treating schizophrenia

    Ground-breaking research has uncovered a new therapeutic approach to treating genetic forms of schizophrenia. Elly Earls meets the lead author of the study to find out about its potential.